Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Passage BIO, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 45 | 46 | +1 |
| Shares | 38.7M | 37.6M | −1.04M (−2.7%) |
| Value | $27.1M | $21.6M | −$5.49M (−20.3%) |
New holders (10)
Institutions that held Passage BIO, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ground Swell Capital, LLC | 25,424 | $14.4K | 0.03% |
| HRT Financial LP | 13,850 | $7.00K | 0.00% |
| Virtu Financial LLC | 10,286 | $6.00K | 0.00% |
| Atria Wealth Solutions, Inc. | 10,000 | $5.67K | 0.00% |
| MAI Capital Management | 4,000 | $2.27K | 0.00% |
| SBI Securities Co., Ltd. | 2,369 | $1.34K | 0.00% |
| BNP Paribas Arbitrage, SA | 186 | $105 | 0.00% |
| Farther Finance Advisors, LLC | 50 | $28 | 0.00% |
| UBS Group AG | 2 | $1 | 0.00% |
| Simplex Trading, LLC | 575 | $0 | 0.00% |
Sold out (9)
Institutions that held Passage BIO, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Citadel Advisors LLC | 402,525 | $281.8K |
| Landscape Capital Management, L.L.C. | 53,915 | $37.7K |
| Engineers Gate Manager LP | 34,770 | $24.3K |
| XTX Topco Ltd | 29,590 | $20.7K |
| Cresset Asset Management, LLC | 23,725 | $16.6K |
| Two Sigma Securities, LLC | 21,635 | $15.1K |
| Nordwand Advisors, LLC | 2,500 | $1.75K |
| Federated Hermes, Inc. | 783 | $548 |
| Northwestern Mutual Wealth Management Co | 64 | $45 |